Zenas BioPharma, Inc. (ZBIO) Net income 2023–2025
Zenas BioPharma, Inc. (ZBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$377.7MFY2025 · since FY2023: -$37.1M → -$377.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$377.7M | -140.6% |
| FY2024 | -$157.0M | -322.9% |
| FY2023 | -$37.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Operating cash flowZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →